Teladoc(US:TDOC)2025-10-29 20:04Financial Performance - For Q3 2025, Teladoc Health reported consolidated revenue of $626.4 million and adjusted EBITDA of $69.9 million[3] - The net loss for the three months ended September 30, 2025, was $49.5 million, compared to a net loss of $33.3 million in Q3 2024[18] - The company reaffirmed its full-year 2025 consolidated revenue and adjusted EBITDA outlook previously issued on July 29, 2025[3] - Adjusted EBITDA for Q3 2025 included total adjustments of $119.4 million, which comprised various costs such as stock-based compensation and goodwill impairments[18] - Teladoc Health emphasizes the importance of adjusted EBITDA as a key measure of performance, excluding certain non-recurring items[9] - The preliminary financial results are subject to change and should not be viewed as a substitute for full financial statements prepared in accordance with GAAP[5] Management Changes - The company is currently searching for a new Chief Financial Officer following the announcement of Mala Murthy's departure[2] Future Outlook - Forward-looking statements indicate potential uncertainties regarding future financial performance and market conditions[6] - The company will host a conference call on October 29, 2025, to discuss its Q3 2025 financial results[4] Strategic Goals - The company aims to enhance access to virtual care and improve health outcomes through its relationships with various stakeholders[19]